Table 1

Reasons for study discontinuation

Reason

PS-DHA

Placebo


Protocol violation

2

1


Withdrawn consent

5

6


Adverse events*

5

5


Severe adverse events**

1#

1##


Sum

13

13


* Adverse events are specified in Table 6

** Classified by the study physician as not related to the study treatment

# Hospitalization due to hyponatremia

## Hospitalization due to atrial fibrillation and epigastric pain

Vakhapova et al. BMC Neurology 2011 11:79   doi:10.1186/1471-2377-11-79

Open Data